Keyword: University of Washington
The Weill Family Foundation is stumping up $106 million to create a so-called “Neurohub.”
Human-generated antibodies have provided new clues that could boost the development of a broadly protective antiviral drug and universal flu vaccine.
The vaccine is built on computationally designed self-assembling VLP technology that Icosavax thinks can eliminate barriers to protecting against RSV.
Through the merger, Neoleukin gets an on-ramp to public financing that will push a computationally designed IL-2 drug.
A combination of cardiac muscle cells and epicardial cells derived from stem cells restored damaged heart tissue in a rat study.
Bioengineers at UCSF and the University of Washington have designed a protein that can be switched on and off inside cells to modulate healing.
They say you are what you eat, but scientists at Rice University and the University of Washington may be taking that maxim a step further.
Guardant Health has moved to acquire Bellwether Bio, which focuses on early cancer diagnostics that tap into the epigenomics of cell-free DNA.
Scientists have used computer programs to design a protein that looks like natural IL-2 but that lacks the toxicities of IL-2 cancer drugs.
Insights into how bacteria hibernate and use metals to evade destruction by antibiotics could be useful in drug development.